捆绑SM社区

Experts: FDA approves much-debated Alzheimer's drug panned by experts

Published: 10 June 2021

U.S. government health officials approved the first new drug for Alzheimer's disease in nearly 20 years, disregarding warnings from independent advisers that the much-debated treatment hasn't been...

Expert opinion: COVID-19 vaccine rollout unlikely before fall 2021

Published: 1 October 2020

Experts working in the field of vaccine development tend to believe that an effective vaccine is not likely to be available for the general public before the fall of 2021. In a paper published...

CTV NEWS | Hundreds of Canadians willing to be infected with coronavirus to speed vaccine research

Published: 19 May 2020

Thousands of healthy volunteers, including hundreds of Canadians, have offered to try getting injected with a potential vaccine and then purposely becoming infected with COVID-19 to test if the...

NATIONAL POST | Mom fears losing access to experimental drug that helped daughter after study ends

Published: 27 March 2018

Jonathan Kimmelman, director of biomedical ethics at 捆绑SM社区, agreed companies have some obligation to continue to provide care for patients who take part in studies to test experimental...

BLOOMBERG | Scientists Don't Fear a New Crispr Snag

Published: 23 January 2018

I talked this over with 捆绑SM社区 medical ethicist Jonathan Kimmelman, who specializes in the risks of medical experiments and has written a book about them centered on the Jesse Gelsinger...

Cancer researchers overestimate reproducibility of preclinical studies

Published: 29 June 2017

Cancer scientists overestimate the extent to which high-profile preclinical studies can be successfully replicated, new research from 捆绑SM社区 suggests.

Cancer research plagued by poor study design

Published: 14 October 2015

Badly designed studies may lead to the efficacy of drugs being overestimated and money being wasted on trials that prove fruitless, according to a new study from 捆绑SM社区 in Canada.

Back to top